New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
September 16, 2013
10:04 EDTAMRE, RGDO, DX, EFC, MFA, SDLP, LOCM, WRI, BFS, TPRE, REG, RPT, KIM, ECYT, EVTC, DDR, BEAV, BMRNOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: AmREIT (AMRE) initiated with an Add at Capital One... BE Aerospace (BEAV) initiated with a Buy at Citigroup... DDR Corp. (DDR) initiated with an Add at Capital One... EVERTEC (EVTC) initiated with a Buy at BofA/Merrill... Endocyte (ECYT) initiated with a Buy at Brean Capital... Kimco Realty (KIM) initiated with a Strong Buy at Capital One... Ramco-Gershenson (RPT) initiated with a Neutral at Capital One... Regency Centers (REG) initiated with an Add at Capital One... Saul Centers (BFS) initiated with an Add at Capital One... Third Point Reinsurance (TPRE) initiated with a Buy at BofA/Merrill... Weingarten Realty (WRI) initiated with a Strong Buy at Capital One... Local (LOCM) initiated with a Buy at Merriman... Seadrill Partners (SDLP) coverage resumed with a Buy at Global Hunter... MFA Financial (MFA) initiated with a Buy at Compass Point... Ellington Financial (EFC) initiated with a Buy at Compass Point... Dynex Capital (DX) initiated with a Buy at Compass Point... Regado Biosciences (RGDO) initiated with an Outperform at Cowen... BioMarin (BMRN) reinstated with a Buy at BofA/Merrill.
Check below for free stories on AMRE;BEAV;DDR;EVTC;ECYT;KIM;RPT;REG;TPRE;BFS;WRI;LOCM;SDLP;MFA;EFC;DX;RGDO;BMRN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 24, 2014
16:24 EDTWRIWeingarten Realty reaffirms 2014 FFO outlook $1.95-$2.01, consensus $2.00
Subscribe for More Information
16:23 EDTWRIWeingarten Realty reports Q2 FFO 51c, consensus 50c
Reports Q2 revenue $130.2M, consensus $124M.
July 23, 2014
08:10 EDTBMRNBioMarin, Sarah Cannon Research UK collaborate on EMBRACA clinical study
BioMarin Pharmaceutical and Sarah Cannon Research UK announced a collaboration to enroll patients in an ongoing Phase 3 clinical trial of its PARP inhibitor, BMN 673, for the treatment of hereditary breast cancer with a BRCA mutation. This ongoing Phase 3 trial has recently been named EMBRACA. Sarah Cannon Research UK enrolled the first patient outside of the United States, expanding the trial internationally.
07:44 EDTBMRNBioMarin survey shows strong Vimizim demand, says Leerink
Subscribe for More Information
05:27 EDTBEAVBE Aerospace raises FY14 EPS view to about $4.35 from about $4.30
Subscribe for More Information
05:24 EDTBEAVBE Aerospace reports Q2 EPS $1.13, consensus $1.07
Subscribe for More Information
July 22, 2014
16:08 EDTRPTRamco-Gershenson acquires two shopping centers for $150M
Ramco-Gershenson Properties Trust announced that it has acquired two strategic, multi-anchored community shopping centers in Minneapolis-St. Paul, Minnesota and Cincinnati, Ohio for approximately $150M. The acquisitions were financed with $58.6M of assumed mortgage debt, $9.9M in disposition proceeds, $60.0M in borrowings under the Company's revolving line of credit, and $21.5M in cash. The Company also announced that in the 1H of FY14 it raised approximately $50M in net cash proceeds by issuing 3.1M common shares through its at-the-market equity program.
16:07 EDTRPTRamco-Gershenson raises FY14 FFO view to $1.22-$1.26 from $1.20-$1.26
Subscribe for More Information
16:06 EDTRPTRamco-Gershenson reports Q2 FFO 31c, consensus 30c
Reports Q2 revenue $49.93M, consensus $49.62M.
15:30 EDTBEAVNotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's market open, with earnings consensus, include PepsiCo (PEP) , consensus $1.23; Boeing (BA), consensus $2.01; Dow Chemical (DOW), consensus 72c; EMC (EMC), consensus 43c; Simon Property Group (SPG), consensus $2.13; Thermo Fisher (TMO), consensus $1.62; General Dynamics (GD), consensus $1.77; Freeport-McMoRan (FCX), consensus 49c; Delta Air Lines (DAL), consensus $1.04; Northrop Grumman (NOC), consensus $2.22; Whirlpool (WHR), consensus $2.91; B/E Aerospace (BEAV), consensus $1.07; Ryder (R), consensus $1.40; Owens Corning (OC), consensus 46c.
July 17, 2014
13:36 EDTSDLPSeadrill Partners increases cash distribution by 7% to 54.25c
Seadrill Partners announced that its board of directors has declared a quarterly cash distribution with respect to the quarter ended June 30 of 54.25c per unit, which represents an increase of approximately 7% from the 1Q14. This increase, as already announced, relates to the acquisition of the ultra-deepwater drillship, the West Auriga, and the company's management recommendation to the board to increase the quarterly distribution rate as a result in respect of the quarter ending June 30. This increase is not influenced by the accretion resulting from the acquisition of additional Seadrill Operating units announced. Distribution increases as a result of this acquisition will follow in subsequent quarters. This cash distribution will be paid on August 12 to all unitholders of record as of the close of business on July 31.
13:31 EDTSDLPSeadrill Partners acquires additional 28% interest in Seadrill Operating
Subscribe for More Information
06:27 EDTTPREPlatinum Q2 may turn reinsurance sentiment negative, says Citigroup
Subscribe for More Information
July 16, 2014
16:16 EDTAMREAmREIT retains Jefferies LLC as financial advisor
Subscribe for More Information
July 15, 2014
16:22 EDTKIMKimco Realty acquires 10 property shopping portfolio for $275.8M
Subscribe for More Information
10:56 EDTBMRNFed calls small cap social media, biotech valuations 'stretched'
The Board of Governors of the Federal Reserve in its Monetary Policy Report dated today said valuation metrics in "some sectors" appear substantially stretched, "particularly those for smaller firms in the social media and biotechnology industries, despite a notable downturn in equity prices for such firms early in the year." A later part in the document reads, "Equity valuations of smaller firms as well as social media and biotechnology firms appear to be stretched, with ratios of prices to forward earnings remaining high relative to historical norms." The specific targeting of sectors by the Fed seems to be having an impact on stocks in the social media and biotech spaces. Shares of Yelp (YELP) are down over 5% to $67.51, while Twitter (TWTR) and Facebook (FB) are each down 2%. Celgene (CELG) and Amgen (AMGN) are leading the biotech space lower with pullbacks of greater than 1%.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use